首页> 美国卫生研究院文献>World Journal of Gastrointestinal Oncology >Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand
【2h】

Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand

机译:泰国东北部肝门周围胆管癌根治性切除的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

AIM: To examine survival outcomes of perihilar cholangiocarcinoma (PCCA) resection including mortality, morbidity and prognostic factors.METHODS: Multivariate analyses were carried out based on the survival data of all patients with histologically confirmed PCCA who underwent curative resection at Srinagarind Hospital from January 2006 to December 2011.RESULTS: There were 29 (19%) cases of intrahepatic CCA that involved hilar and 124 (81%) with hilar bile-duct cancer. R0 resection was carried out on 66 (43.1%) patients of whom 50 (32.7%) also had lymph node metastasis. The other patients underwent R1 resection. The overall 5-year survival rate was 20.6% (95%CI: 13.8-28.4) and median survival time was 19.9 mo. Postoperative mortality was 2%, and 30% of patients had complications. Patients without lymph node metastasis were 60% less likely to die than those with metastasis. Achieving R0 led to a 58% reduction in the chance of mortality as compared to R1.CONCLUSION: To achieve a better survival outcome, focus should center on performing radical surgery and detection of patients with early stage cancer.
机译:目的:研究切除肝门胆管癌(PCCA)的生存结局,包括死亡率,发病率和预后因素。方法:根据2006年1月在Srinagarind医院经组织学证实的所有PCCA患者的生存资料,进行多因素分析。结果:至2011年12月。肝内CCA累及肝门29例(19%),肝门胆管癌124例(81%)。对66例(43.1%)患者进行了R0切除,其中50例(32.7%)也有淋巴结转移。其他患者接受了R1切除。总体5年生存率为20.6%(95%CI:13.8-28.4),中位生存时间为19.9 mo。术后死亡率为2%,有30%的患者有并发症。没有淋巴结转移的患者比有转移的患者死亡的可能性低60%。与R1相比,达到R0可使死亡率降低58%。结论:为获得更好的生存结果,重点应放在进行根治性手术和早期癌症患者的检测上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号